Clinical trials
Myocardial Infarct clinical trials
Below are recruiting myocardial infarct clinical trials, each written for real people, not researchers. We’re tracking 317 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07427199Recruiting
Digital nutrition therapy after heart attack
This study tests whether a digital nutrition program (app- or online-based) can improve heart function after a heart attack. It compares the program to standard care for people who have had a STEMI heart attack.
Samsun, AtakumAges 19–65 - NCT07517523Recruiting
Heart Rhythm Problems During Heart Attack
This study looks at dangerous heart rhythms that happen during a heart attack. Researchers will review medical records from 2012–2024 to understand these rhythms better and potentially improve treatment.
CaenAges 18 years+ - NCT05812963Recruiting
IVUS vs FFR to guide stents after heart attacks
This trial compares two ways of measuring blood flow inside the heart arteries (IVUS vs FFR) to help decide which non–culprit artery narrowings need a stent after a recent heart attack. It may help doctors choose the best targets for PCI and avoid unnecessary procedures.
GwangjuAges 19 years+ - NCT06566625Recruiting
MRI before heart catheterization for heart attack
This trial compares using a cardiac MRI before the standard catheterization (angiogram) in people with a suspected heart attack that doesn't show the typical ECG changes. It aims to see if the MRI can help guide decisions and avoid unnecessary procedures.
Stockholm, SwedenAges 18 years+ - NCT04113356Recruiting
MRI study after first heart attack treated with fast angioplasty
This trial tests how well a heart MRI can be used soon after a first heart attack, especially when a blocked artery is opened quickly with angioplasty. It may help doctors better assess heart injury and guide care after an emergency heart event.
InnsbruckAges 18 years+ - NCT06811194Enrolling by invitation
ECG to detect past heart attacks
This trial uses an electrocardiogram (ECG) to find people who have had a past heart attack or are at high risk for coronary artery disease. It may help understand how ECG patterns relate to heart health.
Chengdu, SichuanAges 35–85 - NCT06515730RecruitingPhase 4
Apixaban vs warfarin for left ventricle clot after heart attack
This trial tests whether a newer blood thinner, apixaban, works better than the standard warfarin for treating blood clots in the left ventricle after a heart attack. The goal is to see which medication is safer and more effective at preventing complications.
FalunAges 18 years+ - NCT04088682Recruiting
Check hospital care quality for adults with heart attacks
This trial looks at how well hospitals measure and deliver care for adults who arrive soon after a certain type of heart attack. It may help improve quality of treatment for people with acute ST-elevation myocardial infarction (a specific heart attack pattern).
Beijing, Beijing MunicipalityAges 18 years+ - NCT04719026Recruiting
Teeth and heart attack link in people with or without heart attacks
This study compares dental health in people who were recently admitted for a heart attack with similar people who have not had a heart attack. It aims to see whether gum and dental health might be related to heart attack risk.
AberdeenAges 20–90 - NCT04912518Recruiting
Dexmedetomidine for heart protection after a specific heart attack
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
Hefei, AnhuiAges 18–75 - NCT05339477Recruiting
Study of activity after a heart attack
This study follows people after a type 1 heart attack to see how physical activity relates to recovery. It may help doctors understand what activity patterns are best after hospitalization.
AlingsåsAges 18–79 - NCT05709626RecruitingPhase 4
Testing prasugrel alone after stent placement for heart attack
This study checks whether taking prasugrel by itself, after you get a drug-eluting stent for a heart attack (STEMI), can work as well as the standard approach. It may help prevent blood clots in the stent, but it requires specific blood-thinner plans for 12 months.
Sayama, OsakaAges 18 years+ - NCT05892042Recruiting
Anticoagulant treatment for a heart clot after a heart attack
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
Changchun, JilinAges 18–80 - NCT06147986RecruitingPhase 2
Stem cell treatment after heart attack
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
TaichungAges 20–75 - NCT06215989Recruiting
Low-dose colchicine for acute coronary syndrome
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06343844Recruiting
Heart attack recovery differences between men and women
This study looks at how men and women recover differently after a first heart attack. By comparing heart function over time, researchers hope to find better ways to treat each gender.
AngersAges 18 years+ - NCT06385834Recruiting
Morning vs Evening Exercise After Heart Attack
This study compares the effects of doing aerobic exercise in the morning versus the evening for people who recently had a heart attack. It aims to see if timing of exercise can help the heart recover and function better.
ShanghaiAges 17–75 - NCT06495177Recruiting
Survey on heart disease and diabetes prevention
This survey studies how well heart disease, diabetes, and kidney disease are being prevented and managed across Europe. If you've had a heart event or are taking medicines for high blood pressure, cholesterol, or diabetes, this study wants to learn from your experience.
IstanbulAges 18 years+ - NCT06586424Recruiting
Can Anion Gap Predict Heart Risks After a Heart Attack?
This study checks if a simple blood test measure (anion gap) can help predict serious heart problems in people who have had a major heart attack (STEMI) and received emergency angioplasty. It may help doctors better understand your risk and guide future care.
Semarang, Central of JavaAges 18–70 - NCT06965023Recruiting
Microplastics in heart attack patients
This trial looks for tiny plastic particles (microplastics and nanoplastics) in blood clots from people having a severe heart attack (STEMI) who need a procedure to open a blocked artery. It may help us understand if these particles are linked to heart attacks.
Roma, RomeAges 18 years+ - NCT06967194Recruiting
Early beta blocker use after heart attack with fast heart rate or low blood pressure
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
Tel AvivAges 18 years+ - NCT07072858Recruiting
Heart MRI to Predict Recovery After Heart Attack
This study is testing if a special heart MRI taken within a week of a STEMI heart attack can help doctors predict your recovery and future risks. It may help tailor your follow-up care.
BeijingAges 18–80 - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+
Hear when a new Myocardial Infarct trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial infarct?
- Yes. Clin2 currently lists 317 recruiting myocardial infarct studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial infarct trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial infarct trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.